首页 | 本学科首页   官方微博 | 高级检索  
     

基于打破树突状细胞耐受的抗肿瘤免疫治疗
引用本文:赵晓鸿,宁振飞,杨荣存. 基于打破树突状细胞耐受的抗肿瘤免疫治疗[J]. 国际免疫学杂志, 2008, 31(4)
作者姓名:赵晓鸿  宁振飞  杨荣存
作者单位:南开大学医学院,天津,300071
摘    要:
树突状细胞(DC)是专职抗原呈递细胞,具有强大的免疫监视功能.由于在诱导免疫反应中的重要作用,DC已被广泛地应用于抗肿瘤免疫治疗.但是由于肿瘤细胞对荷瘤宿主免疫系统,尤其是对DC功能的抑制,使以DC为基础的抗肿瘤免疫治疗疗效受到了很大的限制.所以,通过调节DC功能,可打破肿瘤对DC的免疫抑制,引导有效的抗肿瘤反应,提高以DC为基础的抗肿瘤免疫效果,这在抗肿瘤免疫治疗中具有重要意义.

关 键 词:树突状细胞  免疫耐受  肿瘤免疫治疗

Tumor immunotherapy based on breaking the tolerance of Dendritic cells
ZHAO Xiao-hung,NING Zhen-fei,YANG Rong-cun. Tumor immunotherapy based on breaking the tolerance of Dendritic cells[J]. International Journal of Immunology, 2008, 31(4)
Authors:ZHAO Xiao-hung  NING Zhen-fei  YANG Rong-cun
Abstract:
Dendritic cells(DCs),the most effective professional antigen presenting ceHs in the immune system,are able to induce and regulate different kinds of immune responses.Although DCs have been widely used in tumor immunotherapy,the DC-based therapies against tumors are limited since their function and activity are often inhibited by tumor and/or tumor associated factors.Thus.importance significant if DC ac-tivity could be regulated to resist tumor-induced suppression.In this review,we sumnlarize the current knowledge about the immune therapies by the means of breaking tumor induced suppression on DCs to en-hanee the clinical responses against cancer.
Keywords:Dendritic cell  immune tolerance  tulnor immunotherapy
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号